Market Place
Sourcing Support
All News #Library
Biotech
Merger for troubled liver disease biotech called off
11 Dec 2024 //
FIERCE BIOTECH
Pharma Two B And Hepion File F-4 For Proposed Merger
04 Sep 2024 //
GLOBENEWSWIRE
Hepion Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment
13 Nov 2023 //
GLOBENEWSWIRE
Hepion Pharmaceuticals™ Rencofilstat Demonstrates Anti-Cancer Activity
25 Oct 2023 //
GLOBENEWSWIRE
New Anti-Cancer Opportunities Revealed for Hepion Pharmaceuticals™ Rencofilstat
21 Sep 2023 //
GLOBENEWSWIRE
Hepion Pharmaceuticals Discovers Novel Rencofilstat Action in Liver Cancer
19 Sep 2023 //
GLOBENEWSWIRE
Rencofilstat Produces Positive Outcomes in Translational Study
14 Sep 2023 //
GLOBENEWSWIRE
Hepion boosts confidence in NASH drug hopeful via shorter study
22 May 2023 //
ENDPTS
Hepion Pharmaceuticals Phase 2 ALTITUDE-NASH Trial Achieves Endpoints
22 May 2023 //
GLOBENEWSWIRE
Hepion to Present Data on Synergistic Effects of Rencofilstat with at AACR 2023
17 Apr 2023 //
GLOBENEWSWIRE
EPO Decision to Grant EU Patent for Rencofilstat Strengthens Hepion Patent Portfolio
02 Mar 2023 //
GLOBENEWSWIRE
Anti-Cancer Potential of Rencofilstat Expanded with Results from Myeloma Studies
18 Jan 2023 //
GLOBENEWSWIRE
Presentation of Study Highlighting Activity of Rencofilstat with Proteosome
10 Jan 2023 //
GLOBENEWSWIRE
Hepion Pharma to Present Ph2a Rencofilstat Multiomics Data at NASH-TAG 2023
05 Jan 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.